SCHEMBL7652253

SCHEMBL7652253

CN(C)S(=O)(=O)c1cc2cc(P(=O)(O)O)c(=O)[nH]c2cc1Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
MAPK1 P28482 1/20 0.37
GRIN2D O15399 2/20 0.37
GRIN3B O60391 2/20 0.37
GRIN1 Q05586 2/20 0.37
GRIN2A Q12879 2/20 0.37
GRIN2B Q13224 2/20 0.37
GRIN2C Q14957 2/20 0.37
GRIN3A Q8TCU5 2/20 0.37
GRIA1 P42261 1/20 0.37
GRIA2 P42262 1/20 0.37
GRIA3 P42263 1/20 0.37
GRIA4 P48058 1/20 0.37
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
PKM P14618 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7652678 0.85 KDM4E (0.38) ALDH1A1MAPK1GRIN2DGRIN3BGRIN1
SCHEMBL2844839 0.83 CA12 (0.40) ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6939746 0.82 GRIN2D (0.37) ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7650412 0.82 TSHR (0.37) ALDH1A1MAPK1GRIN2DGRIN3BGRIN1
SCHEMBL7650414 0.82 ALDH1A1 (0.33) ALDH1A1MAPK1GRIN2DGRIN3BGRIN1
SCHEMBL7648730 0.81 GRIN2D (0.35) ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7651540 0.80 GAA (0.41) PKM
SCHEMBL7648786 0.80 GRIN1 (0.35) ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7652701 0.80 KDM4E (0.37) ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7652655 0.80 GSTO1 (0.37) ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486143-B2 NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS LES LABORATOIRES SERVIER (FR) 2002-11-26 US disclosed
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds LES LABORATOIRES SERVIER (FR) 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds CA6, P2RY6, FPR3 ALDH1A1 1221/4885MAPK1 2815/4885GRIN2D 1500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.